UK's MHRA wants your views on no-deal Brexit

4 October 2018 - Deborah Wilkes


The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would have to be modified if the UK does not secure a deal with the European Union after its departure from the European Union and there is no implementation period.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: